For research use only. Not for therapeutic Use.
KT-474（Cat No.:I043444）is an investigational small molecule inhibitor of the enzyme TAK1 (TGF-beta-activated kinase 1), which plays a key role in various inflammatory and immune responses. TAK1 is involved in signaling pathways that regulate the production of pro-inflammatory cytokines and the activation of immune cells. By inhibiting TAK1, KT-474 aims to reduce inflammation and modulate immune responses, offering potential therapeutic benefits for diseases driven by chronic inflammation, such as rheumatoid arthritis, inflammatory bowel disease, and certain cancers. Ongoing clinical trials are assessing KT-474’s safety, efficacy, and potential to treat these inflammatory conditions.
| CAS Number | 2432994-31-3 |
| Synonyms | N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynoxy]piperidin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
| Molecular Formula | C44H49F2N11O6 |
| Purity | ≥95% |
| IUPAC Name | N-[3-(difluoromethyl)-1-[4-[[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]prop-2-ynoxy]piperidin-1-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
| InChI | InChI=1S/C44H49F2N11O6/c1-52-39-27(4-2-6-34(39)57(44(52)61)35-11-12-37(58)50-43(35)60)5-3-19-62-30-13-16-53(17-14-30)22-26-7-9-28(10-8-26)56-24-33(38(51-56)40(45)46)48-42(59)32-21-47-55-18-15-36(49-41(32)55)54-23-31-20-29(54)25-63-31/h2,4,6,15,18,21,24,26,28-31,35,40H,7-14,16-17,19-20,22-23,25H2,1H3,(H,48,59)(H,50,58,60)/t26?,28?,29-,31-,35?/m1/s1 |
| InChIKey | NQGKNAVUMAHSQN-PKIOHZLWSA-N |
| SMILES | CN1C2=C(C=CC=C2N(C1=O)C3CCC(=O)NC3=O)C#CCOC4CCN(CC4)CC5CCC(CC5)N6C=C(C(=N6)C(F)F)NC(=O)C7=C8N=C(C=CN8N=C7)N9C[C@H]1C[C@@H]9CO1 |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
